A riveting tale of how shady investors and crooked brokerages conspired to manipulate the shares of a small drug compnay with some innovative ideas about how to develop cancer drugs. And a blueprint for how these bad actors do the same to other firms...and rip off ordinary investors. Unlike other books on finance, this reads like a thriller or a conspiracy yarn--but it"s all true!